SBOTF News Alert Stellar Biotech Inc (SBOTF) 1.0299 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 15, 2015 at 12:44 PM

Stellar Biotech Inc (SBOTF) 1.0299 $SBOTF

Stellar Biotechnologies Reports First Quarter 2015 Financial Results
Marketwired - Mon Feb 09, 7:30AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, announced financial results for the first quarter period ended December 31, 2014.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference
Marketwired - Thu Jan 08, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company's management team will present at the 7th Annual Biotech Showcase 2015 conference, being held at the Parc 55 Wyndham Hotel in San Francisco, CA, on Tuesday, January 13 at 2:30 p.m. PST.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies to Present at LD Micro Conference
Marketwired - Mon Nov 24, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the Company's management team will present at the upcoming LD Micro Conference on Tuesday, December 2 at 1:00 p.m. PST.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies misses by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:55AM CST

Stellar Biotechnologies Reports Year-End 2014 Financial Results
Marketwired - Thu Nov 13, 9:17AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, has reported preliminary financial results for the year ended August 31, 2014.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies
Marketwired - Tue Nov 11, 11:46AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) and Araclon Biotech SL ("Araclon"

today announced that the companies have executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease.
KLH.VN: 1.280 (-0.030)

Stellar Bio tech chief bids adieu
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:05PM CST

Stellar Biotechnologies Announces Resignation of CTO Effective December 10, 2014
Marketwired - Fri Nov 07, 12:30PM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), today announced the resignation of chief technology officer Herbert Chow, Ph.D. He will be leaving the company on December 10, 2014 for personal reasons. Dr. Chow's responsibilities will be reassigned based on a mutually agreed transitional plan.
KLH.VN: 1.280 (-0.030)

Stellar Bio reports November 13
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:52AM CST

Stellar Biotechnologies Announces Year-End 2014 Conference Call
Marketwired - Thu Nov 06, 7:32AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, will host its year-end 2014 conference call and webcast at 1:30 PM ET (10:30 AM PT) on November 13, 2014.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma
Marketwired - Thu Oct 23, 1:16PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) and Biovest International, Inc. ("Biovest"

today announced that the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin (KLH) for use in Biovest's BiovaxID(R) active immunotherapy to treat follicular non-Hodgkin's lymphoma.
KLH.VN: 1.280 (-0.030)

Market Maker Surveillance Report. INS, VOXX, CNET, GTI, ATOS, SBOTF, Losing Stocks With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:42AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Intelligent Systems Corp (NYSE:INS), VOXX INTERNATIONAL CORP (NASDAQ:VOXX), Chinanet Online Holdings Inc (NASDAQ:CNET), Graftech International Ltd (NYSE:GTI), AUTOMATED SVCS INC (:ATOS), STLG BIOTECH REG S (OTC:SBOTF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
VOXX: 8.85 (+0.10), INS: 2.10 (unch), GTI: 4.16 (+0.32), CNET: 1.58 (+0.02)

Stellar Biotechnologies Analyst Report; Early Mover in Fast Growing Immunotherapy Market by BrokerBank Securities, Inc.
PR Newswire - Fri Sep 05, 6:30AM CDT
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is an emerging contender in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, and infectious diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology.

Market Maker Surveillance Report. TCCO, BTH, PRLS, SBOTF, SGOC, INFI, Winning Stocks With Lowest Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:03AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Technical Communications Corp (NASDAQ:TCCO), Blyth Inc (NYSE:BTH), Peerless Systems Corp (NASDAQ

RLS), STLG BIOTECH REG S (OTC:SBOTF), SOLOMON GOLD CORP (NASDAQ:SGOC), Infinity Pharmaceuticals Inc (NASDAQ:INFI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
BTH: 7.99 (-0.17), PRLS: 6.96 (-0.02), SGOC: 0.56 (-0.03), INFI: 15.13 (+0.55), TCCO: 4.32 (-0.07)

Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference
Marketwire - Tue Sep 02, 11:03AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oakes, the Company's President and CEO, will present at the upcoming Rodman & Renshaw 2014 Global Investment Conference, on Tuesday, September 9, 2014 at 1:15PM ET.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies Reports on Unusual Trading Activity
Marketwire - Fri Aug 29, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) reports that, in view of the unusual market trading activity in the Company's stock, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual market surveillance practice.
KLH.VN: 1.280 (-0.030)

Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments
Marketwire - Thu Jul 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), a leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has reported financial results for the third quarter and nine months ended May 31, 2014, and provided operational highlights.
KLH.VN: 1.280 (-0.030)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...